IndraLab
Statements
reach
"The BRAF V600E mutation is a well-accepted poor prognostic factor in patients with metastatic colorectal cancer (mCRC), as it confers Ras-independent stimulation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway involved in proliferation, migration, angiogenesis and the suppression of apoptosis."
reach
"Since RAS activation and CRAF activity are both low in BRAF V600E tumors, in which MEK and ERK signaling is driven almost entirely by BRAF V600E, we hypothesized that the decreased MEK inhibitor sensitivity of KRAS tumors is due to ineffective inhibition of CRAF driven MEK signaling by these drugs."
reach
"B-RAF V600E mutant protein is constitutively active 51 and earlier studies demonstrated that B-RAF V600E mutant dysregulates NF-kappaB/Snail/RKIP/PTEN circuit as well as activates MEK and ERK kinases that promote the epithelial to mesenchymal transition (EMT) and melanoma cell growth XREF_BIBR, XREF_BIBR."
reach
"Indeed, only one of the three putative B-RAF V600E resistance alleles identified by random mutagenesis produced sustained MEK and ERK signaling upon re-expression and challenge with a selective RAF inhibitor, and none engendered pharmacological resistance to drug sensitive B-RAF V600E melanoma cells based on growth inhibition assays."
reach
"The aforementioned tumor cell lines were chosen because they likely represent two different melanoma subgroups; UCD-Mel-N has an activating mutation, Q61R, at NRAS codon 61 (XREF_SUPPLEMENTARY), whereas A375 displays the BRAF V600E activating mutation, and constitutively active ERK and JNK kinases."
reach
"Indeed, while some studies reported that V600E BRAF activated ERK signalling and promoted proliferation of melanoma cell lines [XREF_BIBR - XREF_BIBR], other data indicated that the presence of mutant BRAF had no impact on the distant metastasis-free survival in melanoma patients [XREF_BIBR]."
reach
"We found that BRAF V600E can upregulate anti-apoptotic MCL-1 in a gene dose dependent manner using colorectal cancer cell lines isogenic for BRAF BRAF V600E -induced MCL-1 upregulation was confirmed by ectopic BRAF V600E expression that activated MEK and ERK signaling to phosphorylate (MCL-1 Thr163) and stabilize MCL-1."
reach
"In vitro studies demonstrate that the resistance of BRAF V600E colorectal cancer cell lines is associated with an adaptive mechanism that utilizes intrinsically high levels of phosphorylated EGFR to engage signaling machinery to activate RAS and, consequently, reactivate the ERK1/2 pathway."